Skip to main content

MoneyWorks4Me

Kwality Pharmaceuticals informs about disclosure

07 May 2025 Evaluate
Kwality Pharmaceuticals has informed that the company has successfully concluded a regulatory audit for Zimbabwe across its General, Beta-Lactam, Cephalosporin and Oncology units, with no critical observations. This marks yet another milestone in its series of successful audits over the past year.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..